These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29666292)

  • 21. Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.
    Marasco WA; LaVecchio J; Winkler A
    J Immunol Methods; 1999 Dec; 231(1-2):223-38. PubMed ID: 10648940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
    Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
    Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase.
    Srivastava DK; Tendler CL; Milani D; English MA; Licht JD; Wilson SH
    AIDS; 2001 Mar; 15(4):433-40. PubMed ID: 11242139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.
    Barillari G; Gendelman R; Gallo RC; Ensoli B
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7941-5. PubMed ID: 7690138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.
    Wu-Baer F; Sigman D; Gaynor RB
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7153-7. PubMed ID: 7638159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VH gene use by HIV type 1-associated lymphoproliferations.
    Ng VL; Hurt MH; Herndier BG; Fry KE; McGrath MS
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):135-49. PubMed ID: 9007199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?
    Parsons MS; Muller S; Kohler H; Grant MD; Bernard NF
    Hum Vaccin Immunother; 2013 Jul; 9(7):1532-8. PubMed ID: 23571168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germinal center function in the spleen during simian HIV infection in rhesus monkeys.
    Margolin DH; Saunders EH; Bronfin B; de Rosa N; Axthelm MK; Goloubeva OG; Eapen S; Gelman RS; Letvin NL
    J Immunol; 2006 Jul; 177(2):1108-19. PubMed ID: 16818768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restriction of AID activity and somatic hypermutation by PARP-1.
    Tepper S; Mortusewicz O; Członka E; Bello A; Schmidt A; Jeschke J; Fischbach A; Pfeil I; Petersen-Mahrt SK; Mangerich A; Helleday T; Leonhardt H; Jungnickel B
    Nucleic Acids Res; 2019 Aug; 47(14):7418-7429. PubMed ID: 31127309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes.
    Weitkamp JH; Lafleur BJ; Greenberg HB; Crowe JE
    Hum Immunol; 2005 Jun; 66(6):666-76. PubMed ID: 15993712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline.
    Kim BO; Liu Y; Ruan Y; Xu ZC; Schantz L; He JJ
    Am J Pathol; 2003 May; 162(5):1693-707. PubMed ID: 12707054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of human antibodies by in vitro immunization using a fusion protein containing the transcriptional transactivator of HIV-1.
    Ait Mebarek M; Wijkhuisen A; Adel-Patient K; Lamourette P; Léonetti M; Volland H
    J Immunol Methods; 2013 Oct; 396(1-2):96-106. PubMed ID: 23954270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.
    Reiss P; de Wolf F; Kuiken CL; de Ronde A; Dekker J; Boucher CA; Debouck C; Lange JM; Goudsmit J
    J Acquir Immune Defic Syndr (1988); 1991; 4(2):165-72. PubMed ID: 1898969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations.
    Hicar MD; Chen X; Kalams SA; Sojar H; Landucci G; Forthal DN; Spearman P; Crowe JE
    Mol Immunol; 2016 Feb; 70():94-103. PubMed ID: 26748387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell-independent somatic hypermutation in murine B cells with an immature phenotype.
    Mao C; Jiang L; Melo-Jorge M; Puthenveetil M; Zhang X; Carroll MC; Imanishi-Kari T
    Immunity; 2004 Feb; 20(2):133-44. PubMed ID: 14975236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen.
    Moreau E; Hoebeke J; Zagury D; Muller S; Desgranges C
    J Virol; 2004 Apr; 78(7):3792-6. PubMed ID: 15016898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Better living with hyper-mutation.
    Goodman MF
    Environ Mol Mutagen; 2016 Jul; 57(6):421-34. PubMed ID: 27273795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased mutation frequencies among immunoglobulin G variable region genes during viremic HIV-1 infection.
    Bowers E; Scamurra RW; Asrani A; Beniguel L; MaWhinney S; Keays KM; Thurn JR; Janoff EN
    PLoS One; 2014; 9(1):e81913. PubMed ID: 24409278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides.
    Moreau E; Belliard G; Partidos CD; Pradezinsky F; Le Buanec H; Muller S; Desgranges C
    J Gen Virol; 2004 Oct; 85(Pt 10):2893-2901. PubMed ID: 15448351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic mutations and activation-induced cytidine deaminase (AID) expression in established rheumatoid factor-producing lymphoblastoid cell line.
    Gil Y; Levy-Nabot S; Steinitz M; Laskov R
    Mol Immunol; 2007 Jan; 44(4):494-505. PubMed ID: 16574227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.